<DOC>
	<DOCNO>NCT00986882</DOCNO>
	<brief_summary>The study ass analgesic efficacy safety tolerability single oral dose SAF312 postoperative dental pain patient 3rd molar extraction .</brief_summary>
	<brief_title>To Evaluate Safety , Tolerability Analgesic Efficacy SAF312 Postoperative Dental Pain Patients</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Extraction two impact ( partial full ) third molar . At least one impaction low jaw . Each patient evaluate her/his postsurgical pain intensity prior take trial medication . To eligible trial , post surgical pain must moderate severe Subjects good health otherwise determine past medical history , physical examination , vital sign , electrocardiogram laboratory test screen . Female subject either postmenopausal surgical sterilization . Patients know hypersensitivity diclofenac , aspirin , acetaminophen antipyretic allergy manifest attack asthma , urticaria acute rhinitis follow treatment aspirin agent cyclooxygenaseinhibiting activity NSAIDs . Use antipyretic/analgesic drug 48 hr predose 24 hr postdose Presence bleeding disorder ( history excessive bleeding dental procedure minor injury ) Patients Diabetes mellitus . Presence , history , family history malignant hyperthermia anesthesiarelated event may suggestive malignant hyperthermia . An abnormal ECG screening , include PR &gt; 200 m , QRS &gt; 110 m , QTcF &lt; 380 &gt; 450 m , lead II T wave abnormality . Nonspecific T wave abnormality lead lead II permissible accompany morphological abnormality . Patients infection e.g . dental abscess Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Postoperative pain</keyword>
</DOC>